Coated glass pharmaceutical packages are disclosed. According to embodiments, a coated glass pharmaceutical package may include a glass container formed from one of a borosilicate glass composition that meets Type 1 criteria according to USP <660> or an alkali aluminosilicate glass having a Class HGA 1 hydrolytic resistance when tested according to the ISO 720-1985 testing standard. A low-friction coating may be bonded to the exterior surface of the glass container. The low-friction coating may include a polymer. The exterior surface of the glass container with the low-friction coating may have a coefficient of friction of less than or equal to 0.7. The coated glass pharmaceutical package may be thermally stable after depyrogenation in air at a temperature of at least about 260° C. for 30 minutes.

Powder coating compositions, particularly metal packaging powder coating compositions, coated metal substrates, and methods; wherein the powder coating compositions include powder polymer particles comprising a polymer having a number average molecular weight of at least 2000 Daltons, wherein the powder polymer particles have a particle size distribution having a D50 of less than 25 microns; and, in certain embodiments, one or more charge control agents in contact with the powder polymer particles.

In slot-die coating, shrinkage of a PVA film when heating after the application of a PVA solution onto an anchor layer formed on the outer surface of a preform for a plastic bottle is suppressed. A leveling agent such as a siloxane is added to the PVA solution.

The object of the present invention is to provide a coating agent for forming a coating film having barrier properties and stretchability and to provide a resin container comprising a coating film formed using the coating agent on a surface thereof, wherein the coating film has high barrier properties and is less prone to film breakage during stretching.

LDH, which is in the form of nanometer-scale particles, is added along with PVA.

The inventive label is prepared from a polyester with an intrinsic viscosity of 0.58 dl/g or more. The label has a base film with a thickness of 8-30 m and a difference in specific heat capacity Cp between temperatures lower and higher than Tg of 0.2 J/(g.Math. C.) or more. The label has a tensile elongation at break of 5% or more in both a main shrinkage direction and an orthogonal direction. A difference between the absorbancy ratio (absorbancy at 1340 cm.sup.1/absorbancy at 1410 cm.sup.1) in the main shrinkage direction of the label and the absorbancy ratio in the direction orthogonal to the main shrinkage direction of the label is 0.2 or more. The label has a difference between a maximum value and a minimum value of a length in a vertical direction of the label of 3 mm or less.

The present invention relates to an aqueous coating composition containing a polyester resin having an acid value of not less than 30 mgKOH/g and less than 70 mgKOH/g as a base resin, and a curing agent having a functional group capable of crosslinking with a carboxyl group. The aqueous coating composition is excellent in workability and can form a coating having favorable curability and corrosion resistance, and thus can be suitably used for a metal container like a beverage can or a metal lid.

A container for alcohol, e.g., a wine bottle, formed of a polycarbonate wall sandwiched between exterior and interior coatings, at least one of which may be an epoxy of 4,4-isopropylidenedicyclohexanol and 1-chloro-2,3,-epoxypropane, crosslinked with 3-aminopropyltriethoxysilane. The polycarbonate wall may be an extrusion blow molded monolithic form at least 1.5 mm thick, and either or both of the exterior coating and the interior coating may have a thickness between 1 nm and 100 m, inclusive.

A glass container for storing pharmaceutical formulations may include a glass body formed from a Type IA or Type IB glass composition according to ASTM Standard E438-92(2011). The glass body may include a wall portion with an inner surface and an outer surface, a heel portion and a floor portion, wherein the inner surface of the glass container is formed by the inner surface of the glass body. The glass body may include at least a class A2 base resistance or better according to ISO 695, at least a type HGB2 hydrolytic resistance or better according to ISO 719 and Type 1 chemical durability according to USP <660>. The glass container does not comprise a boron-rich layer on the inner surface of the glass body in as formed condition.

The present disclosure is directed to pharmaceutical packages that include a coating that comprises polysilazane, and methods for the production of such. In one or more embodiments of the present disclosure, a pharmaceutical package may include a glass container comprising a first surface and a second surface opposite the first surface. The first surface may be an outer surface of the glass container. The pharmaceutical package may further include a coating positioned over at least a portion of the first surface of the glass container. The coating may include polysilazane.

Embodiments of the present disclosure are directed to coated glass articles which reduce glass particle formation caused by glass to glass contact in pharmaceutical glass filling lines.